Cited by 547Respiratory Support and MechanismsInflammation biomarkers and pathwaysNeonatal Respiratory Health Research

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Cytokine Balance in the Lungs of Patients with Acute Respiratory Distress Syndrome

PARK, WILLIAM Y., GOODMAN, RICHARD B., STEINBERG, KENNETH P., RUZINSKI, JOHN T., RADELLA, FRANK, PARK, DAVID R., PUGIN, JEROME, SKERRETT, SHAWN J., HUDSON, LEONARD D., MARTIN, THOMAS R.·2001·American Journal of Respiratory and Critical Care Medicine

DOI 10.1164/ajrccm.164.10.2104013

Open this paper in CoChat — free account

Abstract

Acute respiratory distress syndrome (ARDS) involves an intense inflammatory response in the lungs, with accumulation of both pro- and antiinflammatory cytokines in bronchoalveolar lavage fluid (BALF). Our goal was to determine how the balance between pro- and antiinflammatory mediators in the lungs changes before and after the onset of ARDS. We identified 23 patients at risk for ARDS and 46 with established ARDS and performed serial bronchoalveolar lavage (BAL). We used immunoassays to measure tumor necrosis factor α (TNF- α) and soluble TNF- α receptors I and II; interleukin 1 β (IL-1 β), IL-1 β receptor antagonist, and soluble IL-1 receptor II; IL-6 and soluble IL-6 receptor; and IL-10. We used sensitive bioassays to measure net TNF- α, IL-1 β, and IL-6 activity. Although individual cytokines increased before and after onset of ARDS, greater increases occurred in cognate receptors and/or antagonists, so that molar ratios of agonists/antagonists declined dramatically at the onset of ARDS. The molar ratios remained low for 7 d or longer, limiting the activity of soluble IL-1 β and TNF- α in the lungs at the onset of ARDS. This significant antiinflammatory response early in ARDS may provide a key mechanism for limiting the net inflammatory response in the lungs.

Integrity signals

Registry

Crossref · 10.1164/ajrccm.164.10.2104013

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Acute Respiratory Distress Syndrome
Matthay, M. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342209 · Cited by 4,924
The Acute Respiratory Distress Syndrome
Ware, L. B., & Matthay, M. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421806 · Cited by 4,666
Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., & Kishimoto, T. (1989) · Cell · doi:10.1016/0092-8674(89)90438-8 · Cited by 1,396
Macrophage deactivation by interleukin 10.
Bogdan, C., Yoram Vodovotz, B., & Nathan, C. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.6.1549 · Cited by 1,236
The cytokine handbook
Thomson, A. W. (1994) · Cited by 1,114
Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4
Colotta, F., Re, F., Muzio, M., Bertini, R., Polentarutti, N., Sironi, M., Giri, J. G., Dower, S., Sims, J. E., & Mantovani, A. (1993) · Science · doi:10.1126/science.8332913 · Cited by 979
Comparison of in vitro cell cytotoxic assays for tumor necrosis factor
Flick, D. A., & Gifford, G. E. (1984) · Journal of Immunological Methods · doi:10.1016/0022-1759(84)90147-9 · Cited by 745
IL-6-Induced Homodimerization of gp130 and Associated Activation of a Tyrosine Kinase
Murakami, M., Hibi, M., Nakagawa, N., Nakagawa, T., Yasukawa, K., Yamanishi, K., Taga, T., & Kishimoto, T. (1993) · Science · doi:10.1126/science.8511589 · Cited by 724
Inflammatory Cytokines in the BAL of Patients With ARDS
Meduri, G. U., Kohler, G., Headley, S., Tolley, E., Stentz, F., & Postlethwaite, A. (1995) · Chest · doi:10.1378/chest.108.5.1303 · Cited by 695
IL-6 and APPs: anti-inflammatory and immunosuppressive mediators.
Tilg, H., Dinarello, C., & Mier, J. (1997) · Immunology today (Amsterdam. Regular ed.) · doi:10.1016/s0167-5699(97)01103-1 · Cited by 687

Show all 47 references

Research works printed but not linked: 1

Aarden, 1985, A growth factor for B cell hybridomas produced by human monocytes., Lymphokines, 10, 175

Sorted by citations

Items 501–544 of 544

Ventilator induced lung injury in children in the intensive care
Halbertsma, F. J. J. (2009) · Tijdschrift voor kindergeneeskunde · doi:10.1007/bf03086388
Syndrome de détresse respiratoire aiguë
Guérin, C., & Richard, J. (2011) · Encyclopédie médico-chirurgicale. Pneumologie · doi:10.1016/s1155-195x(11)58056-9
Pulmonary Edema
Matthay, M. A., & Murray, J. F. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-3383-5.00062-2
The Modeling and Advanced Controller Design of Wind, PV and Battery Inverters
Han, J. (2014) · doi:10.33915/etd.5748
Colchicine and SARS-CoV-2 prospects for clinical management of the inflammatory statePreprint
Vitiello, A., & Ferrara, F. (2020) · doi:10.22541/au.159050279.91041958
USE OF COLCHICINE TO COUNTERACT THE STRONG HYPERINFLAMMATORY STATE INDUCED BY SARS-COV-2
Ferrara, F., De Rosa, F., Pelliccia, C., La Porta, R., & Vitiello, A. (2020) · Universal Journal of Pharmaceutical Research · doi:10.22270/ujpr.v5i3.417
Clinical and phamacological analysis of Sars Cov 2: how combination therapy makes checkmatePreprint
Ferrara, F., Granata, G., Pelliccia, C., Porta, R. L., & Vitiello, A. (2020) · doi:10.22541/au.158872395.55078086
The War Against SARS-CoV-2: The Immune Giant Collapsing Under Its Own Rampaging Cytokine Storm
Sofra, X. (2021) · Journal of Endocrinology and Metabolism Research · doi:10.37191/mapsci-2582-7960-2(1)-013
Surfactant proteins and the inflammatory and immune response in the lung
Itto, E. G. (2006)
Pharmacodynamic Study of QingFei Paidu Decoction in the Treatment of Acute Respiratory Distress Syndrome Caused by Coronavirus Disease-2019 (COVID-19)Preprint
Zhi-xian, H., Wang, X., Wang, X., & Wang, J. (2021) · Research Square · doi:10.21203/rs.3.rs-552799/v1
Μελέτη της επίδρασης του αναπνεόμενου όγκου σε μηχανικά αεριζόμενους ασθενείς χωρίς σημαντική πνευμονική βλάβη
Ζιάκα, Μ. (2021) · doi:10.12681/eadd/48842
Porcine model of sepsis-induced systemic inflammation and acute lung injury in donor lungsPreprint
Nasir, B., Ménaouar, A., Landry, C., Germain, J.-F., Laplante, P., Sarkissian, S. D., Liberman, M., Cailhier, J., Leduc, C., Noiseux, N., et al. (2020) · doi:10.21203/rs.3.rs-20516/v1
The Toxicity of Cooking Oil Fumes on Human Bronchial Epithelial Cells Through ROS-Mediated MAPK, NF-κB Signaling Pathways and NLRP3 InflammasomePreprint
Cao, X., Fu, M., Miao, J., Sun, Y., Zhu, R.-G., Liu, C., Bi, R., Wang, S., & Liu, J. (2021) · Research Square · doi:10.21203/rs.3.rs-604026/v1
Predictors of Acute Lung Injury
Freeman, C. A., Dahms, T. E., Bailey, J. A., Lindsay, K., Tricomi, S. M., & Dedert, C. (2013) · doi:10.21236/ada583589
Post-pneumonectomy Pulmonary Edema
Cook, D., Powell, E., & Smith, F. G. (2009) · Springer eBooks · doi:10.1007/978-0-387-92278-2_45
The effect of arnafant surfactant on respiratory distress syndrome in ratsPreprint
Boskabady, M. H., Behrouz, S., Beigoli, S., Ghasemi, S. Z., Boskabady, M., & Roshan, N. M. (2022) · Research Square · doi:10.21203/rs.3.rs-1421357/v1
Hypoxia shapes the immune landscape in lung injury promoting inflammation persistencePreprint
Mirchandani, A. S., Jenkins, S. J., Bain, C. C., Lawson, H., Coelho, P., Murphy, F. A., Griffith, D. M., Zhang, A., Sánchez-García, M. A., Reyes, L., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.11.483935
Investigating Stress Response across Integrated Biological Systems
Han, A. A. (2017) · doi:10.33915/etd.5749
Pulmonary endothelium in acute lung injury: from basic science to the critically ill
Orfanos, S. E., Mavrommati, I., Korovesi, I., & Roussos, C. (2009) · Springer eBooks · doi:10.1007/978-3-642-01769-8_37
WITHDRAWN: Association Between Inflammatory Biomarkers and Acute Respiratory Distress Syndrome or Acute Lung Injury Risk: A Systematic Review and Meta-analysisPreprint
Zhou, Q., Liu, Z., Liu, D., Zou, Y., Wang, H., Li, X. Y., & Zheng, D. (2020) · Research Square · doi:10.21203/rs.3.rs-21170/v1
Faculty Opinions recommendation of IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality.
Criddle, D. N., & Javed, M. A. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717980878.793473612
Polyunsaturated Fatty Acids and Cytokines: Their Relationship in Acute Lung Injury
Cotogni, P., Trombetta, A., Muzio, G., Brizzi, M. F., & Canuto, R. A. (2014) · Springer eBooks · doi:10.1007/978-1-4614-8503-2_112-1
Síndrome de dificultad respiratoria aguda
Guérin, C. (2017) · EMC - Anestesia-Reanimación · doi:10.1016/s1280-4703(17)86785-2 · Cited by 1
Ultra-protective ventilation combined with V-V ECMO has a preferable therapeutic effect on Acute Respiratory Distress Syndrome: An experimental study in aged Beagle dogsPreprint
Wang, X., Wang, A., Zhang, Y., Liu, K., Wang, J., Le, S., Cheng, P., Wang, J., Xue, X., Yu, Y. S., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1639103/v1
To Be or Not to Be Vaccinated? The Perilous Evolution of COVID-19
Sofra, X. (2021) · Archives of Metabolic Syndrome · doi:10.33425/2771-8972.1004
To Be or Not to Be Vaccinated? The Perilous Evolution of COVID-19
Sofra, X. (2021) · Archives of Metabolic Syndrome · doi:10.33425/2771-8972.004
The cytokine level in exhaled breath condensate and cytokine genes polymorphism in children with bronchial asthma
Малинчик, М. А., Gorbacheva, N., Belenjuk, V. D., Сергеевна, К. О., & Smolnikova, M. V. (2022) · Siberian medical review · doi:10.20333/25000136-2022-2-78-87
Hemoadsorption (CytoSorb®) in Management of Cytokine Storm and Implication in COVID-19 Pandemic
Prasad, S. M., Mishra, S., Maheshwarappa, H. M., Joshi, S. S., & Premkumar, R. J. (2022) · Journal of Acute Care · doi:10.5005/jp-journals-10089-0019
Evaluation of DPP4/CD26 Potential Role for the Management of Inflammation in COVID-19 Patients
Akbarian, F., Chafjiri, S. R., Poornabi, M., Khani, F., Abolhasanzadeh, S., & Hosseini, F. (2023) · Current Respiratory Medicine Reviews · doi:10.2174/1573398x19666230724155039
Ultrasound and Microbubbles for Targeted Drug Delivery to the Lung Endothelium in ARDS: Cellular Mechanisms and Therapeutic Opportunities
Sanwal, R., Joshi, K., Ditmans, M., Tsai, S. S. H., & Lee, W. L. (2023) · doi:10.32920/24026667.v1
Additional file 3 of Exosomal miR-30d-5p of neutrophils induces M1 macrophage polarization and primes macrophage pyroptosis in sepsis-related acute lung injury
Jiao, Y., Zhang, T., Zhang, C., Ji, H., Tong, X., Ran, X., Wang, W., Ma, Z., & Shi, X. (2021) · Figshare · doi:10.6084/m9.figshare.16800680
The role of angiogenesis-related genes in sepsis-induced acute respiratory distress syndromePreprint
Fan, J., Guo, Q., Liang, J., Huo, J., Wu, S., Wang, T., Wu, W., & Bai, X. (2024) · Research Square · doi:10.21203/rs.3.rs-4733659/v1
Syndrome de détresse respiratoire aiguë
(2014) · Médecine Intensive Réanimation · doi:10.1016/b978-2-294-08855-1.50083-8
Acute respiratory distress syndrome
Bersten, A. D., & Bihari, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-11611-7.00037-2
Additional file 5 of Lyophilized powder of mesenchymal stem cell supernatant attenuates acute lung injury through the IL-6–p-STAT3–p63–JAG2 pathway
Peng, W., Chang, M., Wu, Y., Zhu, W., Tong, L., Zhang, G., Wang, Q., Liu, J., Zhu, X., Cheng, T., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14337606
Additional file 3 of Lyophilized powder of mesenchymal stem cell supernatant attenuates acute lung injury through the IL-6–p-STAT3–p63–JAG2 pathway
Peng, W., Chang, M., Wu, Y., Zhu, W., Tong, L., Zhang, G., Wang, Q., Liu, J., Zhu, X., Cheng, T., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14337597
Additional file 4 of Lyophilized powder of mesenchymal stem cell supernatant attenuates acute lung injury through the IL-6–p-STAT3–p63–JAG2 pathway
Peng, W., Chang, M., Wu, Y., Zhu, W., Tong, L., Zhang, G., Wang, Q., Liu, J., Zhu, X., Cheng, T., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14337600
Additional file 2 of Lyophilized powder of mesenchymal stem cell supernatant attenuates acute lung injury through the IL-6–p-STAT3–p63–JAG2 pathway
Peng, W., Chang, M., Wu, Y., Zhu, W., Tong, L., Zhang, G., Wang, Q., Liu, J., Zhu, X., Cheng, T., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14337594
Additional file 1 of Lyophilized powder of mesenchymal stem cell supernatant attenuates acute lung injury through the IL-6–p-STAT3–p63–JAG2 pathway
Peng, W., Chang, M., Wu, Y., Zhu, W., Tong, L., Zhang, G., Wang, Q., Liu, J., Zhu, X., Cheng, T., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14337591
Additional file 1 of Exosomal miR-30d-5p of neutrophils induces M1 macrophage polarization and primes macrophage pyroptosis in sepsis-related acute lung injury
Jiao, Y., Zhang, T., Zhang, C., Ji, H., Tong, X., Xia, R., Wang, W., Ma, Z., & 石学银 (2021) · Figshare · doi:10.6084/m9.figshare.16800674
Additional file 2 of Exosomal miR-30d-5p of neutrophils induces M1 macrophage polarization and primes macrophage pyroptosis in sepsis-related acute lung injury
Jiao, Y., Zhang, T., Zhang, C., Ji, H., Tong, X., Xia, R., Wang, W., Ma, Z., & 石学银 (2021) · Figshare · doi:10.6084/m9.figshare.16800677
Proinflammatory and Antiinflammatory Mediators in Critical Illness
Remick, D. G. (2008) · Springer eBooks · doi:10.1007/978-1-84800-921-9_18
Participation des fibroblastes et des fibrocytes aux mécanismes de réparation pulmonaire au cours des agressions alvéolaires aiguës
Quesnel, C. (2009) · theses.fr (ABES) · doi:10.70675/56825ff7zb353z4f57z94b3z3d11cb33f63e
Tocilizumab for the treatment of acute exacerbation of idiopathic pulmonary fibrosis: A matched case-control retrospective study
Guo, B., Huang, J., Chen, G., Chen, X., Feng, D., Deng, H., Lan, X., Deng, Y., Luo, Q., & Han, Q. (2026) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666261480225

Authors: PARK, W. Y., GOODMAN, R. B., STEINBERG, K. P., RUZINSKI, J. T., RADELLA, F., PARK, D. R., PUGIN, J., SKERRETT, S. J., HUDSON, L. D., & MARTIN, T. R.
Affiliations: University of Geneva (CH)
Section of Pulmonary/Critical Care Medicine, Harborview Medical Center, Medical Research Service of the VA Puget Sound Health Care System; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, Washington; and Department of Medical Intensive Care, University of Geneva Medical Center, Geneva, Switzerland
ORCID: SKERRETT, SHAWN J.
Venue: American Journal of Respiratory and Critical Care Medicine
Publisher: Oxford University Press (OUP)
Published: 2001-11
Volume: 164
Issue: 10
Pages: 1896-1903
ISSN: 1073-449X (ISSN-L)
1535-4970
DOI: 10.1164/ajrccm.164.10.2104013
OpenAlex: W2093084020
Cited by: 547
References: 47
Citations by year: 2026: 2 · 2025: 10 · 2024: 8 · 2023: 18 · 2022: 25 · 2021: 43 · 2020: 44 · 2019: 22 · 2018: 18 · 2017: 17 · 2016: 17 · 2015: 20 · 2014: 22 · 2013: 19 · 2012: 26
FWCI: 16.44
Type: journal article
Language: en
Open access: closed
Licence: academic.oup.com/pages/standard-publication-reuse-rights (vor)
Locations: American Journal of Respiratory and Critical Care Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01ai029103-08)
National Heart, Lung, and Blood Institute (P50HL030542, HL-30542)
National Institute of Allergy and Infectious Diseases (AI-29103)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Neonatal Respiratory Health Research
Keywords: acute respiratory distress syndrome, cytokine balance, bronchoalveolar lavage fluid, TNF-α, soluble TNF receptors, IL-1β, interleukin-6, soluble IL-6 receptor, IL-10, anti-inflammatory response, lung inflammation, cytokine antagonists
MeSH terms: Adult, Biological Assay, Bronchoalveolar Lavage Fluid, Female, Humans, Immunoassay, Inflammation, Interleukin-1, Lung, Male, Middle Aged, Prospective Studies, Respiratory Distress Syndrome, Risk Factors, Time Factors, Tumor Necrosis Factor-alpha, Antigens, CD, Interleukin-6, Case-Control Studies, Cytokines, Interleukin-10, Receptors, Interleukin-1, Receptors, Tumor Necrosis Factor, Inflammation Mediators, Receptors, Interleukin-6, Receptors, Tumor Necrosis Factor, Type I, Receptors, Tumor Necrosis Factor, Type II

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cytokine Balance in the Lungs of Patients with Acute Respiratory Distress Syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks